Pavlidis, Polychronis <br/><br/>
Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.  [electronic resource] 

 -  Inflammatory bowel diseases  07 2016 
 - 1639-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0000000000000827  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Allopurinol--adverse effects<br/>Antimetabolites--adverse effects<br/>Azathioprine--adverse effects<br/>Blood Sedimentation<br/>C-Reactive Protein--metabolism<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Colitis, Ulcerative--blood<br/>Crohn Disease--blood<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Intestinal Mucosa<br/>Male<br/>Methyltransferases--blood<br/>Middle Aged<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult